Ten-million-person study links semaglutide to lower COVID-19 mortality
After accounting for major health differences between semaglutide users and non-users, researchers identified a striking mortality association that…
Semaglutide and tirzepatide linked to fewer alcohol-related hospital visits
A large US health-record study suggests newer GLP-1 drugs may reduce alcohol-related acute-care visits, but the findings remain…
Popular diabetes drugs do not alter the risk of developing a blinding eye condition
An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs) – a type of…
Physical activity declines after starting GLP-1 obesity treatments
Adults with obesity losing weight with glucagon-like peptide-1 (GLP-1) receptor agonist medications significantly decreased their physical activity, which…
Weight loss drugs like Ozempic also improve liver health | Health
(Photo by Haberdoedas Photography via Pexels) By Talker By Stephen Beech Popular weight loss drugs such as Ozempic…
Metformin’s blood sugar control starts in the brain, not just the liver, study finds
Scientists uncover how low-dose metformin targets brain pathways to lower blood sugar, opening fresh avenues for safer and…
Which GLP-1 meds have the most side effects? Study of 60,000 Facebook posts gives answers
A deep dive into public Facebook posts uncovers the real-world side effect patterns of GLP-1 medications, revealing what…